Researchers who were searching for signs of Middle East respiratory syndrome coronavirus (MERS-CoV) in different livestock animals have found antibodies specific to the new virus in dromedary camels. This suggests that these animals have encountered MERS-CoV, or a closely related virus, and may be one reservoir of the virus that is causing MERS in humans. The results of this study, led by RIVM-researchers, were published today in The Lancet Infectious Diseases.
Reusken, et al. (2013)Â extracted sera from animals in the Middle East and from Spain, Netherlands and Chile. Cattle, sheep, goats, dromedary camels and other camelid species were tested for specific serum IgG by protein microarray using the receptor-binding S1 subunits of spike proteins of MERS-CoV, severe acute respiratory syndrome coronavirus, and human coronavirus OC43. Results were confirmed by virus neutralization tests for MERS-CoV and bovine coronavirus.
The researchers found that 100 percent of sera from Middle Eastern camels and 14 percent from Spanish camels had protein-specific antibodies against MERS-CoV spike. Sera from European sheep, goats, cattle, and other camelids had no such antibodies. The researchers say that MERS-CoV or a related virus has infected camel populations, and that titres and seroprevalences in sera from different locations in the Middle East suggest widespread infection.
Reference: Reusken C, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. The Lancet Infectious Diseases, Early Online Publication, Aug. 9, 2013 doi:10.1016/S1473-3099(13)70164-6
Managerial Challenges: Setting Boundaries and Priorities in the Workplace
May 3rd 2024Maintaining boundaries can be challenging in a culture of overwork. In this installment of Dear Helpdesk, learn how to communicate effectively with your boss, prioritize your values, and safeguard your work-life balance.
Comprehensive Guide to Lymphedema: Causes, Prevention, and Management Strategies
May 3rd 2024Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses
May 2nd 2024Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?